Partnerships & collaborations - a core part of Affitech's future

Affitech highly values collaborations and partnerships as an effective and efficient model of antibody discovery and development.

The Company has established productive partnerships with biotechnology companies such as Peregrine and Omeros, pharmaceutical companies such as Roche and a number of world renowned charitable trusts and academic institutes.

Affitech sees partnerships as a core part of its future and is willing to discuss different types of risk sharing discovery, development and commercial partnerships for antibodies derived from its proprietary technology platform.

For example a R&D partnership with Russian IBC Generium allows the Company’s partner to develop and commercialize two named products in Russia/CIS whilst Affitech retains product rights in the rest of the world.